tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MYOV

MYOV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsMYOV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
11M ago
MYOV
Three new option listings and option delistings on March 21st
PremiumThe Fly
Three new option listings and option delistings on March 21st
1y ago
FSTX
MYOV
Myovant Sciences reports Q3 EPS (59c), consensus (47c)
PremiumThe Fly
Myovant Sciences reports Q3 EPS (59c), consensus (47c)
1y ago
MYOV
Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022
PremiumPress Releases
Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022
1y ago
MYOV
Lyell Immunopharma appoints Seely as President, CEO
PremiumThe Fly
Lyell Immunopharma appoints Seely as President, CEO
1y ago
LYEL
MYOV
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
PremiumPress ReleasesMyovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
1y ago
MYOV
Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources
PremiumPress Releases
Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources
1y ago
MYOV
Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
PremiumPress Releases
Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
1y ago
MYOV
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
PremiumPress Releases
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
2y ago
MYOV
CORRECTION — Myovant Sciences, Inc.
PremiumPress Releases
CORRECTION — Myovant Sciences, Inc.
2y ago
MYOV
Myovant Sciences to Host Second Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m.
PremiumPress Releases
Myovant Sciences to Host Second Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m.
2y ago
MYOV
Myovant Sciences Rejects Sumitovant’s $2.4 Billion Acquisition Offer
PremiumMarket News
Myovant Sciences Rejects Sumitovant’s $2.4 Billion Acquisition Offer
2y ago
MYOV
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
PremiumPress ReleasesMyovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
2y ago
MYOV
Myovant Recognizes Prostate Cancer Awareness Month with Educational Sponsorships and Online Campaign to Encourage Patients to Speak Up, Seek Support and Be Informed
PremiumPress Releases
Myovant Recognizes Prostate Cancer Awareness Month with Educational Sponsorships and Online Campaign to Encourage Patients to Speak Up, Seek Support and Be Informed
2y ago
MYOV
Myovant Sciences to Participate at Upcoming Investor Conferences
PremiumPress Releases
Myovant Sciences to Participate at Upcoming Investor Conferences
2y ago
MYOV
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
PremiumPress Releases
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
2y ago
MYOV
Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis
PremiumPress Releases
Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis
2y ago
MYOV
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
PremiumPress Releases
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
2y ago
MYOV
Myovant Sciences to Host First Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m. Eastern Time on July 27, 2022
PremiumPress Releases
Myovant Sciences to Host First Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m. Eastern Time on July 27, 2022
2y ago
MYOV
Myovant Sciences and Pfizer Announce Publication in The Lancet of Phase 3 SPIRIT 1 and SPIRIT 2 Studies of Once-Daily Relugolix Combination Therapy in Women With Endometriosis-Associated Pain
PremiumPress ReleasesMyovant Sciences and Pfizer Announce Publication in The Lancet of Phase 3 SPIRIT 1 and SPIRIT 2 Studies of Once-Daily Relugolix Combination Therapy in Women With Endometriosis-Associated Pain
2y ago
MYOV
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
PremiumPress Releases
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
2y ago
MYOV
Why Did Myovant Sciences Close in the Red on Tuesday?
PremiumMarket News
Why Did Myovant Sciences Close in the Red on Tuesday?
2y ago
MYOV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >